Absence of rebound effect with calcium carbonate

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 21, Issue 4, 1996, Pages 351-357

  Simoneau, G ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Antacids; Calcium carbonate; Gastric acid 'rebound'; Hydrotalcite; Intragastric pH

Indexed keywords

ANTACID AGENT; CALCIUM CARBONATE; HYDROTALCITE; MAGNESIUM CARBONATE; RENNIE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFICACY; DRUG MIXTURE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; REBOUND; STOMACH PH;

EID: 0030485247     PISSN: 03787966     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03189738     Document Type: Article

References (15)

1. Vatier J , Ramdani A., Vitré M.T., Mignon M. (1994): Antacid activity of calcium carbonate and hydrotalcite tablets. Comparison between in vitro evaluation using the 'artificial stomach-duodenum' model and in vivo pH-metry in healthy volunteers. Arzneimittelforschung.,. 44, 514-518.
2. Yalow R.S., Berson S.A. (1970): Radioimmunoassay of gastrin. Gastroenterology, 58, 1-14.
3. Peterson W.L., Sturdevant R A.L., Frankl H.D. et al. (1977): Healing of a duodenal ulcer with antacid regimen. N. Engl. J. Med., 297, 341-345.
4. Tamawski A. (1990): Cytoprotective drugs. Focus on antacids. Drug Invest., 2 (suppl. 1), 1-6.
5. Powell D.W. (1984): Physiological concepts of epithelial barriers. In: Allen A. et al. (eds.). Mechanisms of Mucosal Protection in the Upper Gastrointestinal Tract. New York: Raven Press, 1-5.
6. Weberg R., Berstad A., Lange O., Schulz T., Aubert E. (1985): Duodenal ulcer healing with four antacid tablets daily. Scand. J. Gastroenterol., 20, 1041-1045.
7. Rydning A., Weberg A., Lange O., Berstad A. (1986): Healing of benign gastric ulcer with low-dose antacids and fiber diet. Gastroenterology, 91, 56-61.
8. Barreras R.F (1970): Acid secretion after calcium carbonate in patients with duodenal ulcer. N. Engl. J. Med., 282, 1402-1405.
9. Reeder D.D., Coulee J.L., Thompson J.C. (1971): Calcium carbonate antacid and serum gastrin concentration in duodenal ulcer. Surg. Forum, 22, 308-310.
10. Levant J.A., Walsh J.H., Isenberg J.I. (1973): Stimulation of gastric secretion and gastrin release by single oral doses of calcium carbonate in man. N. Engl. J. Med., 289, 555-558.
11. Fordtran J.S. (1968): Acid rebound. N. Engl. J. Med., 279, 900-905.
12. Brunton L.L. (1992): Agents for control of gastric acidity and treatment of peptic ulcers. In: Goodman & Gilman's. The Pharmacological Basis of Therapeutics. 8th edn, Vol. II, 908.
13. Schubert M.L., Edwards N.F., Makhlouf G.M. (1988): Regulation of gastric somatostatin secretion in the mouse by luminal acidity; a local feedback mechanism. Gastroenterology, 94, 317-322.
14. Greenberg G.R., Fung L., Pokol-Daniel S. (1993): Regulation of somatostatin-14 and -28 secretion by gastric acid in dogs: differential role of cholecystokinin. Gastroenterology, 105, 1387-1395.
15. Hürlimann S., Michel K., Inauen W., Halter F. (1996): Effect of Rennie Liquid vs Maalox Liquid on the intragastric pH in a double-blind, randomized placebo controlled triple cross over study in healthy volunteers. Am. J. Gastroenterol., 91, 1173-1180.